Clinical Trial Update: Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for autologous oral mucosal cell sheet transplantation after endoscopic submucosal dissection in superficial esophageal cancer; trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Esophageal Cancer

Drugs mentioned

• Autologous oral mucosal cell sheet transplantation after endoscopic submucosal dissection

Snippet

Sponsor: CellSeed Inc. | Conditions: Superficial Esophageal Cancer | Phase 3 | Status: COMPLETED